GNTA
Genenta Science (GNTA)
$48
About Genenta Science (GNTA)
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.
Details
Daily high
$1.52
Daily low
$1.39
Price at open
$1.39
52 Week High
$10.00
52 Week Low
$1.28
Market cap
26.6M
Dividend yield
0.00%
Volume
28,474
Avg. volume
123,964
P/E ratio
-2.72
Genenta Science News
Details
Daily high
$1.52
Daily low
$1.39
Price at open
$1.39
52 Week High
$10.00
52 Week Low
$1.28
Market cap
26.6M
Dividend yield
0.00%
Volume
28,474
Avg. volume
123,964
P/E ratio
-2.72